Skip to main content

. 1990 Jul 14;301(6743):97. doi: 10.1136/bmj.301.6743.97

Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.

M Lavelle-Jones ¹, A al-Hadrani ¹, E M Spiers ¹, F C Campbell ¹, A Cuschieri ¹

PMCID: PMC1663428 PMID: 2390593

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Buchan G., Barrett K., Fujita T., Taniguchi T., Maini R., Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol. 1988 Feb;71(2):295–301. [PMC free article] [PubMed] [Google Scholar]
Eberlein T. J., Schoof D. D., Michie H. R., Massaro A. F., Burger U., Wilmore D. W., Wilson R. E. Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer. Arch Surg. 1989 May;124(5):542–547. doi: 10.1001/archsurg.1989.01410050032005. [DOI] [PubMed] [Google Scholar]
Jíra M., Malkovský M., Denman A. M., Loveland B., Lyons D., Dalgleish A. G., Webster A. D. Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol. 1987 Jun;68(3):535–542. [PMC free article] [PubMed] [Google Scholar]
Karsh J., Klippel J. H., Plotz P. H., Decker J. L., Wright D. G., Flye M. W. Lymphapheresis in rheumatoid arthritis. A randomized trial. Arthritis Rheum. 1981 Jul;24(7):867–873. doi: 10.1002/art.1780240701. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES